creepy / vacant brain Feminism Festival in Norway

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
290
creepy / vacant brain Feminism Festival in Norway Bars
Israeli Participants Citing ‘Culture as Whitewashing Occupation

< >

femen-protesters-behind-getty-640x480.jpg

A group of Israeli women were barred from participating in a femininity and gender identity festival in Norway over what the organizers described as Israel’s “propaganda,” which uses culture to “whitewash or justify its occupation of the Palestinian people.”
Eden Wiseman, Roni Rotem, Nitzan Lederman, Maayan Cohen Marciano, Adi Shildan and Maia Halter were rejected from joining “Feminine Tripper,” slated for this Saturday in Oslo on political grounds, Ynet reported.

“We regret to have to inform you that after careful consideration we have decided we cannot at this moment invite Israeli participants to our festival,” organizers Kristiane Nerdrum Bøgwald and Margrete Slettebø wrote to the women.



“The reason that we have made this decision is that we cannot, with a clear conscience, invite Israeli participants when we know that artists from the occupied Palestinian territories struggle with very restricted access to travel to international art venues and that they have little opportunity to communicate their art outside of the occupied territories.”

advertisement


There is nothing to support the claim that Palestinians cannot travel to international art venues. Palestinians from the West Bank are permitted to enter more countries than Israelis and frequently do. Palestinians in Gaza may have more restrictions but those are imposed by the ruling Hamas government.

“We also have reason to believe that the Israeli government at the moment uses culture as a form of propaganda to whitewash or justify its regime of occupation and oppression of the Palestinian people,” the organizers added.

The organizers included a link to a 2005 article from Haaretz‘s English website on the Ministry of Foreign Affairs’ decision to increase budgeting for Israeli cultural exposure worldwide.

“We appreciate your artistic project and hope to have the opportunity to invite you to Norway again once the political circumstances have changed,” they added. “We hope that you—as artists—will help raise awareness in your society about the concern many of us artists and cultural workers around the world have about the brutal effects of the occupation on Palestinian artists and the rest of the population.”

The Israeli artists responded by calling the decision hypocritical.

“We find that your decision to deny participation in the festival from Israeli artists is encouraging division and the continuum of conflicts rather than setting an example of another path to the world—one that meets the values of inclusiveness, freedom of speech and expression, dialogue, openness, seeing beyond labels and multiplied perspectives.


“Instead of using the same strategies you are coming out against, which can be defined as generalization and collective sanctions, we think that in order to make real change we all should (adopt) different strategies than the ones we oppose.”

The Israelis also took the organizers to task for using a 2005 article as a basis for its decision, saying, “Artists (in Israel) are fighting in order to obtain their freedom of speech and expression due to recent censorship attempts by the Israeli minister of culture. Surprisingly as it might sound, Maayan and Adi’s works were marginalized both by our own minister of culture and by your own festival.

“Would you reject a Spanish artist for the Spanish policy against Catalonia and the Basques? Would you reject a Saudi artist for Saudi restrictions on women’s rights? Would you reject an American artist for the American policies regarding the ‘Muslim ban’ regulations? Would you reject a Syrian artist for bloodshed caused by the Syrian government? Would you reject an Iranian artist for the forceful reaction to the last uprising in the country?

“If we were Muslim Arab Israeli artists, Christian Arab Israeli artists, Bedouin-Israeli artists, Circassian-Israeli artists, Druze-Israeli artists or Jewish-Israeli artists living abroad, would we have been denied participation in your festival as well?

“We are confused. Your decision to deny access to Israeli artists seems to go against your mission and values, as it is not based on an artistic appropriation of our works, but on political reasons. The only conclusion we can come to is that (this) is an act of reverse-discrimination.”

Festival organizers Bøgwald and Slettebø acknowledged receiving the Israeli reply, but said their decision stood. They promised to elaborate on it once their “heavy workload” of preparing for the festival was over.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading